Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

L-Carnitine and Reduced Low-Density Lipoprotein Level

Research synthesisModerate evidenceSmall effect4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial small-sized effects of L-carnitine supplementation on reducing low-density lipoprotein (LDL) levels, while 1 study found neutral effects. The most robust evidence comes from a high-quality meta-analysis in adults with type 2 diabetes (n=2041) showing a small reduction in LDL (MD: -0.11 mmol/L). Doses ranged from 1 g/day to >2 g/day, and effects were consistently small in magnitude.

  • Effective dose range: 1–2+ g/day
  • Studied populations: adults with type 2 diabetes, hemodialysis patients

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The effect size is small and its clinical significance may be modest. One systematic review in hemodialysis patients found no significant effect on VLDL, suggesting benefits may not extend to all lipid subfractions or populations.

Generated May 13, 2026
Doses used in studies
  • g/day: 1 (median 1, IQR 1–1) — 1 study
4 of 4 papers
Back to top